MOLOGEN Lifescience AG (FRA:U1DA)
Germany · Delayed Price · Currency is EUR 2.960
+0.160 (5.71%)
At close: Aug 26, 2026
MOLOGEN Lifescience AG Revenue
In the year 2021, MOLOGEN Lifescience AG had annual revenue of 45.12K EUR.
Revenue
45.12K
Revenue Growth
n/a
P/S Ratio
90.53
Revenue / Employee
22.56K
Employees
1
Market Cap
4.08M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 45.12K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 15.52K | -81.48K | -84.00% |
| Dec 31, 2017 | 97.00K | 73.00K | 304.17% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Blue Cap AG | 136.46M |
| Pyramid AG | 74.23M |
| Laiqon AG | 34.88M |
| CR Energy AG | 15.22M |
| Scherzer & Co. AG | 13.01M |
| Bitcoin Group SE | 10.05M |
| Shareholder Value Beteiligungen AG | 7.12M |
| Heliad AG | 328.00K |